ATXI
Geode Capital Management’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-52,160
| Closed | -$7.69K | – | 4633 |
|
2024
Q1 | $7.69K | Hold |
52,160
| – | – | ﹤0.01% | 4569 |
|
2023
Q4 | $8.48K | Sell |
52,160
-411
| -0.8% | -$67 | ﹤0.01% | 4602 |
|
2023
Q3 | $37K | Hold |
52,571
| – | – | ﹤0.01% | 4494 |
|
2023
Q2 | $60.5K | Buy |
52,571
+41,141
| +360% | +$47.3K | ﹤0.01% | 4465 |
|
2023
Q1 | $13.4K | Sell |
11,430
-104
| -0.9% | -$122 | ﹤0.01% | 4747 |
|
2022
Q4 | $13K | Buy |
+11,534
| New | +$13K | ﹤0.01% | 4822 |
|
2022
Q3 | – | Sell |
-84,033
| Closed | -$22K | – | 5048 |
|
2022
Q2 | $22K | Hold |
84,033
| – | – | ﹤0.01% | 4911 |
|
2022
Q1 | $40K | Buy |
84,033
+6,620
| +9% | +$3.15K | ﹤0.01% | 4849 |
|
2021
Q4 | $70K | Sell |
77,413
-6,933
| -8% | -$6.27K | ﹤0.01% | 4807 |
|
2021
Q3 | $125K | Buy |
84,346
+4,790
| +6% | +$7.1K | ﹤0.01% | 4611 |
|
2021
Q2 | $199K | Sell |
79,556
-53,038
| -40% | -$133K | ﹤0.01% | 4344 |
|
2021
Q1 | $804K | Buy |
132,594
+7,333
| +6% | +$44.5K | ﹤0.01% | 3648 |
|
2020
Q4 | $745K | Buy |
125,261
+8,225
| +7% | +$48.9K | ﹤0.01% | 3458 |
|
2020
Q3 | $1.27M | Buy |
117,036
+209
| +0.2% | +$2.26K | ﹤0.01% | 3118 |
|
2020
Q2 | $1.26M | Buy |
116,827
+46,712
| +67% | +$503K | ﹤0.01% | 3070 |
|
2020
Q1 | $626K | Buy |
70,115
+2,204
| +3% | +$19.7K | ﹤0.01% | 3202 |
|
2019
Q4 | $651K | Buy |
67,911
+113
| +0.2% | +$1.08K | ﹤0.01% | 3419 |
|
2019
Q3 | $404K | Hold |
67,798
| – | – | ﹤0.01% | 3542 |
|
2019
Q2 | $427K | Buy |
+67,798
| New | +$427K | ﹤0.01% | 3524 |
|